News
Common virus could trigger Parkinson's disease
Digest more
In my sixth year of Parkinson's, cognitive changes leave me wondering how much of this decline is due to the disease and how ...
New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...
The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.
People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...
Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...
The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback